| RCL |
ROYAL CARIBBEAN CRUISES LTD |
Holtz Naftali |
Officer
|
2026-02-13 |
S - D |
12,710 |
328.49 |
4,175,107.90 |
35,768 |
| RCL |
ROYAL CARIBBEAN CRUISES LTD |
Holtz Naftali |
Officer
|
2026-02-13 |
S - D |
5,792 |
329.46 |
1,908,232.32 |
29,976 |
| RCL |
ROYAL CARIBBEAN CRUISES LTD |
Holtz Naftali |
Officer
|
2026-02-13 |
S - D |
815 |
330.36 |
269,243.40 |
29,161 |
| RCL |
ROYAL CARIBBEAN CRUISES LTD |
Holtz Naftali |
Officer
|
2026-02-13 |
S - D |
856 |
331.42 |
283,695.52 |
28,305 |
| RCL |
ROYAL CARIBBEAN CRUISES LTD |
Holtz Naftali |
Officer
|
2026-02-13 |
S - D |
189 |
332.19 |
62,783.91 |
28,116 |
| RTX |
RTX Corp |
DaSilva Kevin G |
Officer
|
2026-02-13 |
S - D |
185 |
200.67 |
37,124.10 |
35,053 |
| RTX |
RTX Corp |
DaSilva Kevin G |
Officer
|
2026-02-13 |
S - D |
7,951 |
201.31 |
1,600,621.38 |
27,102 |
| SNCR |
SYNCHRONOSS TECHNOLOGIES INC |
Rendino Kevin |
Director
|
2026-02-13 |
D - D |
52,768 |
0.00 |
0.00 |
0 |
| RBBN |
Ribbon Communications Inc. |
McClelland Bruce William |
Director
Officer
|
2026-02-13 |
P - A |
12,500 |
1.98 |
24,750.00 |
1,516,164 |
| SNCR |
SYNCHRONOSS TECHNOLOGIES INC |
Rinne Kristin S. |
Director
|
2026-02-13 |
D - D |
59,956 |
0.00 |
0.00 |
0 |
| SNCR |
SYNCHRONOSS TECHNOLOGIES INC |
Rinne Kristin S. |
Director
|
2026-02-13 |
D - D |
2,648 |
0.00 |
0.00 |
0 |
| SNCR |
SYNCHRONOSS TECHNOLOGIES INC |
Rinne Kristin S. |
Director
|
2026-02-13 |
D - D |
1,310 |
0.00 |
0.00 |
0 |
| SNCR |
SYNCHRONOSS TECHNOLOGIES INC |
Rinne Kristin S. |
Director
|
2026-02-13 |
D - D |
2,056 |
0.00 |
0.00 |
0 |
| TROW |
PRICE T ROWE GROUP INC |
Robert W. Sharps |
|
2026-02-13 |
A - A |
150 |
103.92 |
15,615.41 |
556,007 |
| TROW |
PRICE T ROWE GROUP INC |
Robert W. Sharps |
|
2026-02-13 |
A - A |
22,254 |
0.00 |
0.00 |
578,261 |
| MLYS |
Mineralys Therapeutics, Inc. |
Rodman David Malcom |
Officer
|
2026-02-13 |
M - A |
3,541 |
10.20 |
36,118.20 |
53,978 |
| MLYS |
Mineralys Therapeutics, Inc. |
Rodman David Malcom |
Officer
|
2026-02-13 |
S - D |
3,541 |
27.33 |
96,775.53 |
50,437 |
| MLYS |
Mineralys Therapeutics, Inc. |
Rodman David Malcom |
Officer
|
2026-02-13 |
M - A |
4,166 |
14.25 |
59,365.50 |
54,603 |
| MLYS |
Mineralys Therapeutics, Inc. |
Rodman David Malcom |
Officer
|
2026-02-13 |
S - D |
4,166 |
27.33 |
113,856.78 |
50,437 |
| MLYS |
Mineralys Therapeutics, Inc. |
Rodman David Malcom |
Officer
|
2026-02-13 |
S - D |
6,348 |
27.58 |
175,100.06 |
44,089 |
| MLYS |
Mineralys Therapeutics, Inc. |
Rodman David Malcom |
Officer
|
2026-02-13 |
M - D |
3,541 |
0.00 |
0.00 |
127,501 |
| MLYS |
Mineralys Therapeutics, Inc. |
Rodman David Malcom |
Officer
|
2026-02-13 |
M - D |
4,166 |
0.00 |
0.00 |
100,001 |
| ROIV |
Roivant Sciences Ltd. |
QVT Financial LP |
|
2026-02-13 |
S - D |
150,784 |
26.49 |
3,994,268.16 |
15,352,329 |
| ROIV |
Roivant Sciences Ltd. |
QVT Financial LP |
|
2026-02-13 |
S - D |
225,000 |
26.50 |
5,962,500.00 |
15,127,329 |
| ROIV |
Roivant Sciences Ltd. |
Gold Daniel Allen |
|
2026-02-13 |
S - D |
150,784 |
26.49 |
3,994,268.16 |
15,352,329 |